Show metadata Hide metadata

(19)

(11)

2 721 771

(13)

(51)

IPC

A61K31/197(2006-01-01)

A61P35/02(2006-01-01)

B82B1/00(2006-01-01)

(21) (22)

Application

2019112033, 2019-04-19

(24)

Start date

2019-04-19

(22)

Actual filing date

2019-04-19

(45)

Published

2020-05-22

(72)

Inventor

Tsymbal Sergej AlekseevichTatarskij Viktor VyacheslavovichVinogradov Vladimir ValentinovichShtil Aleksandr Albertovich

(73)

Holder

Obshchestvo S Ogranichennoj Otvetstvennostyu

USE OF COMPOSITION OF COPPER OXIDE NANOPARTICLES AND N-ACETYLCYSTEINE FOR DEATH INDUCTION OF CELLS OF CHRONIC MYELOID LEUKAEMIA Russian patent published in 2020 - IPC A61K31/197 A61P35/02 B82B1/00

Abstract RU 2721771 C1

FIELD: medicine; pharmaceuticals.

SUBSTANCE: present invention relates to use of a pharmaceutical composition containing nanoparticles of copper (II) oxide (CuO) and N-acetylcysteine in an effective amount for inducing cell death of chronic myeloid leukaemia.

EFFECT: present invention provides efficacy of the composition with respect to inducing cell death of chronic myeloid leukaemia of various types, regardless of their resistance to other anti-tumour preparations, for example, BCR-ABL inhibitors, cooperative resistance.

4 cl, 4 dwg, 3 ex

Similar patents RU2721771C1

Title	Year	Author	Number
METHOD OF OPTIMISING THERAPY OF PHILADELPHIA CHROMOSOME POSITIVE LEUKAEMIA BY Ab1-TYROSINE KINASE INHIBITORS	2007	Gatmann Inza Maon Fransua-Av'Er Molimar Mat'E Pikar Stefan Van Jan'Fehn	RU2483732C2
METHOD FOR EFFECTIVE INDUCTION OF APOPTOSIS IN SUSPENSION CULTURE OF TUMOR BONE MARROW CELLS Ph AND LEUKEMIC PATIENT PERIPHERAL BLOOD USING ANTI-SENSE OLIGONUCLEOTIDES SPECIFIC TO MRNA OF GENES INHIBITING APOPTOSIS	2002	Grineva N.I. Akhlynina T.V. Gerasimova L.P. Manakova T.E. Krutov A.A. Kulikova V.F. Levina A.S.	RU2240125C2
CANCER TREATMENT	2005	Berni Dzhejms Piter Mehtt'Juz Rut Kristin Karter Trehjsi	RU2389507C2
METHOD FOR QUANTITATIVE DETERMINATION OF G250E MUTATION OF BCR-ABL KINASE DOMAIN FOR PATIENTS WITH CHRONIC MYELOID LEUKOSIS RESISTANT TO THYROSINKINASE INHIBITORS THERAPY	2016	Tikhonova Vera Vyacheslavovna Kesaeva Laura Arturovna Finashutina Yuliya Pavlovna Misyurin Andrej Vitalevich	RU2620076C1
METHOD FOR QUANTITATIVE DETERMINATION OF MUTATIONS F317L AND F359V/C OF THE KINASE DOMAIN BCR-ABL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RESISTANT TO THERAPY WITH TYROSINE KINASE INHIBITORS	2019	Tikhonova Vera Vyacheslavovna Kesaeva Laura Arturovna Finashutina Yuliya Pavlovna Misyurin Andrej Vitalevich Semochkin Sergej Vyacheslavovich Kasatkina Nataliya Nikolaevna	RU2698461C1
ADMINISTRATION OF MIDOSTAURIN FOR TREATING GASTROINTESTINAL STROMAL TUMOURS	2005	Kols Jan	RU2410098C2
ANTI-IL1RAP ANTIBODIES AND THEIR USE FOR TREATING HUMAN	2012	Fioretos Toas Jeros Markus	RU2597831C2
COMPOSITIONS AND METHODS FOR TARGET ELIMINATION OF MUTATION ESCAPE IN TARGET CANCER THERAPY	2008	Ehjpelian Dehvid Frantsuzoff Aleks Rodell Timoti K.	RU2505313C2
TREATING IMANITIB-RESISTANT LEUKAEMIA WITH USE OF 4-AMINOQUINOLINE-3-CARBONITRYL	2008	Kh'Juz Bekker	RU2464026C2
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS	2006	Rehn' Pinda Grej Natanaehl S. Van Sja Chzhan Guobao	RU2383545C2

RU 2 721 771 C1

Authors

Tsymbal Sergej Alekseevich

Tatarskij Viktor Vyacheslavovich

Vinogradov Vladimir Valentinovich

Shtil Aleksandr Albertovich

Dates

2020-05-22—Published

2019-04-19—Filed